| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cc0a2ae02c1653495c31fc9edd4ec8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02d7bbc8704e0f9769af152e5b0994cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_175b741cc1eea0ac89458724ce46ec5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3abc27ba19ddfd262dd53336bdad1307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70accbd77df49682c0cd95b200198df6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d300ef7e48f8b4e55d0b394dcb94eba4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate |
2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b5e740ef85e647ea379e4337d83d6a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59667074360555ea9bd2395bc2987fd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_522ed731e1ef874e5593c7688145b904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4338c07745613850c537cd9f752284d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86fb45e1aa05d96d2f867c9680f23b3d |
| publicationDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007145253-A1 |
| titleOfInvention |
NF-ϰB ACTIVATION INHIBITOR |
| abstract |
The object is to provide a highly safe NF-ϰB activation inhibitor at a low cost which can be used for the prevention or treatment of a disease associated with the activation of NF-ϰB such as an inflammation or type-2 diabetes. Specifically, the NF-ϰB activation inhibitor comprises a compound represented by the chemical structural formula depicted in Chemical Formula 1 [wherein R1 represents a hydroxy group; R2 represents a hydroxy group, a methoxy group or an alkoxy group; and R3 represents an ester comprising a triterpene or a salt thereof] or a salt of the compound as an active ingredient. Arepresentative example of the compound is a hydroxycinnamic acid derivative triterpene alcohol ester. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020161221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110540528-A |
| priorityDate |
2006-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |